Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Credit: KDKA CBS 2 Pittsburgh

Duration: 00:40s 16 Nov 2020 0 shares 4 views

Reporter Update: Moderna's COVID-19 Vaccine Candidate Shows 94.5% Efficacy In Phase 3 Trials

Moderna announced Monday that their COVID-19 vaccine candidate is showing 94.5% efficacy; KDKA's Amy Wadas reports.

You might like

Related news coverage

Managing Vaccine Expectations

Managing Vaccine Expectations

KIMT 30 Nov 2020

The news about two covid-19 vaccines has been absolutely remarkable

Governor adds 19 counties to mask mandate

Governor adds 19 counties to mask mandate

WAPT

24 Nov 2020

Health Headlines - 11-20-20

Health Headlines - 11-20-20

FOX 47 News Michigan

21 Nov 2020

Reporter Update: Local Doctor Takes Part In Moderna Vaccine Trials

Reporter Update: Local Doctor Takes Part In Moderna Vaccine Trials

KDKA CBS 2 Pittsburgh

17 Nov 2020

Moderna says its COVID-19 vaccine candidate is 94.5% effective

Moderna says its COVID-19 vaccine candidate is 94.5% effective

NBC 26 Wisconsin

17 Nov 2020

Advertisement

More coverage

Second COVID vaccine shows promise

Second COVID vaccine shows promise

A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials,..

FOX 4 Now Florida 16 Nov 2020